FTC sues key pharmacy gain administrators above insulin rates The company introduced action in opposition to Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the record price of daily life-preserving insulin medicines. Earlier this summer, the agency held lengthy negotiations with Steward more https://kylersjzpg.wssblogs.com/30668157/how-much-you-need-to-expect-you-ll-pay-for-a-good-healthcare-news